Guardant Health’s $50B Bet Sparks Growth Debate
Guardant Health targets a $50B market with liquid biopsy but struggles with losses and fierce competition, raising questions about its growth runway.
May 4, 20261 min read0 reactions0 comments
Tag archive
Guardant Health targets a $50B market with liquid biopsy but struggles with losses and fierce competition, raising questions about its growth runway.